News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
259,885 Results
Type
Article (13889)
Company Profile (293)
Press Release (245703)
Section
Business (79512)
Career Advice (151)
Deals (13202)
Drug Delivery (31)
Drug Development (50290)
Employer Resources (31)
FDA (5688)
Job Trends (5131)
News (144330)
Policy (10039)
Tag
Academia (909)
Alliances (21531)
Alzheimer's disease (729)
Approvals (5651)
Artificial intelligence (60)
Bankruptcy (97)
Best Places to Work (4480)
Biotechnology (241)
Breast cancer (57)
Cancer (573)
Cardiovascular disease (52)
Career advice (132)
CAR-T (44)
Cell therapy (149)
Clinical research (39603)
Collaboration (202)
Compensation (83)
COVID-19 (999)
C-suite (53)
Cystic fibrosis (61)
Data (612)
Diabetes (64)
Diagnostics (1214)
Earnings (28620)
Events (46615)
Executive appointments (154)
FDA (5931)
Funding (208)
Gene editing (48)
Gene therapy (127)
GLP-1 (290)
Government (1067)
Healthcare (6552)
Infectious disease (1028)
Inflammatory bowel disease (89)
IPO (7180)
Job creations (860)
Job search strategy (127)
Layoffs (181)
Legal (1379)
Lung cancer (101)
Manufacturing (66)
Medical device (2582)
Medtech (2583)
Mergers & acquisitions (6102)
Metabolic disorders (203)
Neuroscience (909)
NextGen Class of 2024 (2001)
Non-profit (848)
Northern California (783)
Obesity (117)
Opinion (93)
Parkinson's disease (55)
Patents (45)
People (24948)
Pharmaceutical (48)
Phase I (13918)
Phase II (18407)
Phase III (11694)
Pipeline (139)
Postmarket research (846)
Preclinical (5873)
Radiopharmaceuticals (203)
Rare diseases (140)
Real estate (1419)
Regulatory (8175)
Research institute (938)
Southern California (722)
Startups (1964)
United States (6588)
Vaccines (153)
Weight loss (74)
Date
Today (173)
Last 7 days (507)
Last 30 days (1820)
Last 365 days (20713)
2024 (17712)
2023 (22458)
2022 (26902)
2021 (27875)
2020 (23413)
2019 (16329)
2018 (11822)
2017 (13804)
2016 (11908)
2015 (14401)
2014 (10424)
2013 (7513)
2012 (7568)
2011 (7656)
2010 (7450)
Location
Africa (148)
Asia (16802)
Australia (2825)
California (1775)
Canada (646)
China (134)
Colorado (65)
Connecticut (71)
Europe (36187)
Florida (191)
Georgia (51)
Illinois (112)
Indiana (55)
Kansas (54)
Maryland (259)
Massachusetts (1478)
Michigan (45)
Minnesota (82)
New Jersey (482)
New York (540)
North Carolina (381)
Northern California (783)
Ohio (73)
Pennsylvania (375)
South America (210)
Southern California (722)
Texas (181)
Washington State (198)
259,885 Results for "grid therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer
Veracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and Cancer.
May 22, 2024
·
5 min read
Business
Infinimmune Announces Partnership with Grid Therapeutics to Conduct Deep Sequencing of B Cells for Oncology Drug Discovery
Infinimmune today announced a partnership with Grid Therapeutics (“Grid”), a clinical stage biotechnology company that focuses on human-derived antibodies, to collaborate in identifying new antibody drug candidates for non-small cell lung cancer.
December 19, 2023
·
3 min read
Biotech Bay
Veracyte Announces that New Afirma GRID Data Suggest Prognostic Ability of Molecular Testing for Thyroid Tumors
Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced new research findings suggesting the potential of novel molecular signatures to identify patients with thyroid nodules or cancer who have aggressive disease.
June 3, 2024
·
8 min read
Biotech Bay
Veracyte Announces that Findings Published in JCO Precision Oncology Suggest Potential of Decipher GRID-Derived Gene Signatures to Predict Treatment Response in Recurrent Prostate Cancer
Veracyte Announces that Findings Published in JCO Precision Oncology Suggest Potential of Decipher GRID-Derived Gene Signatures to Predict Treatment Response in Recurrent Prostate Cancer.
August 22, 2023
·
5 min read
Drug Development
Grid Therapeutics Initiates a Phase 2 Investigator-Sponsored Trial of GT103 in Combination with Merck’s Pembrolizumab in Patients with Advanced Stage Non-Small Cell Lung Cancer
Grid Therapeutics , LLC today announced the initiation of a combination Phase 2 investigator-sponsored study of its lead asset, GT103.
February 22, 2023
·
2 min read
Bio NC
Grid Therapeutics Announces Upcoming Scientific Presentation at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
Grid Therapeutics, LLC announced today a poster presentation at the Society for Immunotherapy of Cancer’s 37th Annual Meeting (SITC 2022), to be held in Boston, Massachusetts and virtually on November 8-12, 2022.
November 3, 2022
·
2 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Biotech Bay
New Data To Be Presented at 2023 ASCO GU Suggest Decipher GRID-Derived Gene Expression Signature Can Help Personalize Prostate Cancer Treatment
Veracyte, Inc. (Nasdaq: VCYT) announced new data being presented this week at the 2023 American Society of Clinical Oncology Genitourinary (ASCO GU) Symposium which demonstrate that a gene expression signature derived from the company’s proprietary Decipher Genomics Resource for Intelligent Discovery (GRID) database may help physicians further personalize treatment for men with prostate cancer, based on their tumor’s molecular subtype.
February 13, 2023
·
6 min read
Biotech Bay
New Data Suggest Decipher GRID-Derived Genomic Signature Can Help Identify Men with Prostate Cancer Who Should Receive High-Dose Radiotherapy
Veracyte, Inc . (Nasdaq: VCYT) announced new data demonstrating that a genomic signature derived from the company’s Decipher GRID database could help determine which men experiencing prostate cancer progression following radical prostatectomy (RP).
October 25, 2022
·
6 min read
Sirona Biochem Provides Update on Loan - February 15, 2024
Sirona Biochem Corp. announce that, further to its news release on January 29, 2024, it has entered into an amendment to the demand grid promissory note dated September 22, 2023 with 0906462 B.C. Ltd.
February 15, 2024
·
4 min read
1 of 25,989
Next